Collagen & Gelatin Companies

The global collagen & gelatin market is projected to reach USD 1,671.3 million in 2030 from USD 1,295.5 million in 2025 at a CAGR of 5.8% during the forecast period. The rising prevalence of chronic diseases, growing demand for advanced wound care products, increasing use of collagen as a drug delivery system, surge in surgical procedures, and wide use in tissue engineering and regenerative medicine drive the collagen & gelatin market.

Some of the major players in the collagen & gelatin market include Integra LifeSciences Corporation (US), Smith+Nephew plc (UK), DSM-Firmenich (Netherlands), Nitta Gelatin Inc. (Japan), and Tessenderlo Group (Belgium). These companies have adopted various strategies, such as the development and launch of advanced collagen and gelatin products, partnerships, contracts, expansions, and acquisitions, to strengthen their position in the collagen and gelatin market. Organic and inorganic strategies have helped the market players expand globally by offering collagen and gelatin products.

To know about the assumptions considered for the study download the pdf brochure

In March 2024, Integra Life Sciences received US FDA approval to commercialize a dermal regeneration template for the repair of scar contractures.

In May 2023, DSM from the Netherlands and Firmenich from Switzerland merged to create DSM-Firmenich, forming one of the largest communities for innovation and creation in nutrition, health, and beauty.

Integra LifeSciences leads in the collagen & gelatin market. It operates through two business segments, namely Codman Specialty Surgical and Tissue Technologies. The company offers engineered bovine collagen, bovine dermis, porcine urinary bladder, human amniotic tissue, and resorbable synthetic mesh products through its Tissue Technologies Segment. This segment recorded a decline of 3.3% in 2024 over 2023 due to the impact of the lost revenue related to the Boston product recall, which was partially offset by double-digit growth from BioD and Gentrix and mid-single-digit growth in Integra skin and MediHoney. The company’s leading position is attributable to its diversified product portfolio, geographical expansion, and adoption of organic and inorganic growth strategies. For instance, in March 2024, Integra Life Sciences received an US FDA approval to commercialize a dermal regeneration template for repairing scar contractures.

Smith+Nephew is one of the leading players in the collagen & gelatin market due to its robust portfolio, including innovative collagen-based scaffolds and collagenase-based enzymatic debridement agents. The company operates through three business segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers collagen and gelatin products through its advanced wound management business segment. Additionally, the company’s strong global presence, strategic partnerships, and commitment to customer-centric solutions position it as a key player in the competitive collagen and gelatin space. The company possesses a strong geographical presence with a broad range of distribution networks to solidify its leadership in the collagen and gelatin market. The advanced wound management business segment of Smith+Nephew has experienced a positive growth rate of 4.7% in the year 2024 and maintained positive momentum in 2024, with growth accelerating toward the end of the year.

Market Ranking, 2024

The collagen & gelatin market is competitive, with five main players collectively holding 45–50% of the total market share. Integra LifeSciences Corporation leads in the collagen & gelatin market, while Smith+Nephew maintains a strong position due to its robust portfolio, including innovative collagen-based scaffolds and collagenase-based enzymatic debridement agents. DSM-Firmenich leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of organic and inorganic growth strategies. Nitta Gelatin Inc. benefits from a well-established product line, namely beMatrix, positioning the company at the forefront of regenerative medicine. Tessenderlo Group strongly focuses on product commercialization, supporting a renowned position in the collagen & gelatin market.

The remaining 50–55% of the market is shared among other regional and emerging vendors, contributing to extensive fragmentation and offering opportunities for smaller players to establish a footprint. The leading market players are based in the US and Europe. Dominant market players have numerous advantages, such as a strong geographic presence, a comprehensive product portfolio, and strategic mergers, acquisitions, and collaborations. Numerous small players operate at regional and global levels.

Related Reports:

Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Orthopedic, Cardiovascular, Dental, Surgical), Competitive Landscape (Company Profile, Market share, Company Evaluation Matrix), End User, and Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com